Welcome to our dedicated page for Protect Pharmace news (Ticker: PRTT), a resource for investors and traders seeking the latest updates and insights on Protect Pharmace stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Protect Pharmace's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Protect Pharmace's position in the market.
Protect Pharmaceutical Corp. (PRTT) announced a partnership with Aetsoft, focusing on technology and product development in sectors such as FinTech and Healthcare. This collaboration aims to leverage Aetsoft's expertise in innovative technologies, including AI and blockchain, to enhance product offerings. The companies plan to share knowledge and develop new solutions, driving growth for both parties. Additionally, PRTT aims to combine its financials with Aetsoft to achieve fully-reporting status with the SEC, enhancing transparency and market presence.
Protect Pharmaceutical Corp. (PRTT) has announced its intention to acquire INAI App Corp, a company specializing in Artificial Intelligence technology. This acquisition includes the innovative 'Human Scanner Software,' designed for security scanning in public venues like airports and hospitals. The software uses advanced computer vision and machine learning to quickly detect threats such as guns and bombs. Following the merger, INAI's founder, Nikolai Grebenkine, will lead the new entity, indicating a promising direction for the technology.
Protect Pharmaceutical Corp (OTC: PRTT) has initiated a turnaround strategy powered by its merger with PUMA, aiming to recover revenue levels of $100 million achieved by PUMA in 2012. The company has consolidated its assets, reducing debt to nearly zero, and plans to introduce innovative green technologies in biopolymers for packaging and industrial design. PRTT anticipates generating profits exceeding $500,000 on revenues of $6 million by the end of 2021, marking the beginning of its revenue growth trajectory.